U.S. flag

An official website of the United States government

NM_000329.3(RPE65):c.1249G>C (p.Glu417Gln) AND multiple conditions

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Nov 29, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001323215.7

Allele description [Variation Report for NM_000329.3(RPE65):c.1249G>C (p.Glu417Gln)]

NM_000329.3(RPE65):c.1249G>C (p.Glu417Gln)

Gene:
RPE65:retinoid isomerohydrolase RPE65 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
1p31.3
Genomic location:
Preferred name:
NM_000329.3(RPE65):c.1249G>C (p.Glu417Gln)
Other names:
NM_000329.3(RPE65):c.1249G>C
HGVS:
  • NC_000001.11:g.68431371C>G
  • NG_008472.2:g.23589G>C
  • NM_000329.3:c.1249G>CMANE SELECT
  • NP_000320.1:p.Glu417Gln
  • NC_000001.10:g.68897054C>G
  • NG_008472.1:g.23589G>C
  • NM_000329.2:c.1249G>C
  • Q16518:p.Glu417Gln
Protein change:
E417Q
Links:
UniProtKB: Q16518#VAR_017141; dbSNP: rs62636299
NCBI 1000 Genomes Browser:
rs62636299
Molecular consequence:
  • NM_000329.3:c.1249G>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Leber congenital amaurosis 2 (LCA2)
Synonyms:
AMAUROSIS CONGENITA OF LEBER II; Amaurosis congenita of Leber, type 2; RPE65-Related Leber Congenital Amaurosis
Identifiers:
MONDO: MONDO:0008765; MedGen: C1859844; Orphanet: 65; OMIM: 204100
Name:
Retinitis pigmentosa 20 (RP20)
Synonyms:
RP 20
Identifiers:
MONDO: MONDO:0013425; MedGen: C3151086; Orphanet: 791; OMIM: 613794

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001514122Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Pathogenic
(Nov 29, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Mutation of key residues of RPE65 abolishes its enzymatic role as isomerohydrolase in the visual cycle.

Redmond TM, Poliakov E, Yu S, Tsai JY, Lu Z, Gentleman S.

Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13658-63. Epub 2005 Sep 6.

PubMed [citation]
PMID:
16150724
PMCID:
PMC1224626

Negative charge of the glutamic acid 417 residue is crucial for isomerohydrolase activity of RPE65.

Nikolaeva O, Takahashi Y, Moiseyev G, Ma JX.

Biochem Biophys Res Commun. 2010 Jan 22;391(4):1757-61. doi: 10.1016/j.bbrc.2009.12.149. Epub 2009 Dec 30.

PubMed [citation]
PMID:
20043869
PMCID:
PMC2812700
See all PubMed Citations (7)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV001514122.4

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This sequence change replaces glutamic acid, which is acidic and polar, with glutamine, which is neutral and polar, at codon 417 of the RPE65 protein (p.Glu417Gln). This variant is present in population databases (rs62636299, gnomAD 0.0009%). This missense change has been observed in individual(s) with autosomal recessive Leber congenital amaurosis (PMID: 11462243). ClinVar contains an entry for this variant (Variation ID: 98835). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RPE65 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects RPE65 function (PMID: 16150724, 20043869, 24849605, 26427455). This variant disrupts the p.Glu417 amino acid residue in RPE65. Other variant(s) that disrupt this residue have been observed in individuals with RPE65-related conditions (PMID: 11462243, 31630094), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 26, 2024